During June 20th to the 23rd, founder and CEO of BioViva USA Inc, Elizabeth Parrish visited Moscow at the invitation of board member of t...

BioViva USA Inc. files for patent for dual gene therapy to restore telomere attrition and muscle degradation caused by aging In 2015 the ...

The 2b AHEAD ThinkTank Future Congress ranks as one of the most attractive events in the European innovation scene. For the last 15 years...

American woman gets biologically younger after gene therapies Elizabeth Parrish, CEO of Bioviva USA Inc. has become the first human being...

London-based investment fund brings Seattle-based biotech startup into its portfolio. London, U.K., 19 April 2016 Summary: Seattle-based ...

Alzheimer’s cure

Reversing Alzheimer’s by Lengthening Telomeres There are telomere lengthening compounds available right now for use in research labs. The...

Bioviva and Telocyte

BioViva would like to thank Dr Michael Fossel for this blog spot and in recognizing the importance of our work. BioViva will be using FDA...

This 2011 paper by Dr DePinho builds on previous papers and his theory of the “telomere-p53-PGC axis”. This is a big reason along with th...

BioViva, an ambitious biotech startup, aims to cure diseases using gene therapy. It is the first company to recognize aging as a disease ...